Your browser doesn't support javascript.
loading
Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma.
Windisch, Paul; Röhrich, Manuel; Regnery, Sebastian; Tonndorf-Martini, Eric; Held, Thomas; Lang, Kristin; Bernhardt, Denise; Rieken, Stefan; Giesel, Frederik; Haberkorn, Uwe; Debus, Jürgen; Adeberg, Sebastian.
Afiliación
  • Windisch P; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Röhrich M; Department of Nuclear Medicine, Heidelberg University Hospital, Germany.
  • Regnery S; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Tonndorf-Martini E; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Held T; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Lang K; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Bernhardt D; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Rieken S; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany.
  • Giesel F; Department of Nuclear Medicine, Heidelberg University Hospital, Germany.
  • Haberkorn U; Department of Nuclear Medicine, Heidelberg University Hospital, Germany; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelber
  • Adeberg S; Department of Radiation Oncology, Heidelberg University Hospital, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Germany; National Center for Tumor Diseases (NCT), Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelber
Radiother Oncol ; 150: 159-163, 2020 09.
Article en En | MEDLINE | ID: mdl-32598977
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Irlanda